Primary |
Maintenance Of Anaesthesia |
42.0% |
General Anaesthesia |
10.3% |
Sedation |
9.1% |
Drug Use For Unknown Indication |
7.9% |
Induction Of Anaesthesia |
7.9% |
Anaesthesia |
6.9% |
Analgesic Therapy |
2.9% |
Analgesic Effect |
2.7% |
Pain |
1.7% |
Postoperative Analgesia |
1.5% |
Pain Management |
1.0% |
Premedication |
1.0% |
Product Used For Unknown Indication |
1.0% |
Analgesia |
0.7% |
Anticoagulant Therapy |
0.7% |
Endotracheal Intubation |
0.7% |
Anxiety |
0.5% |
Depression |
0.5% |
Epidural Anaesthesia |
0.5% |
Labour Pain |
0.5% |
|
Low Birth Weight Baby |
53.5% |
Hypoxia |
7.9% |
Respiratory Depression |
6.3% |
Vocal Cord Disorder |
6.3% |
Toxicity To Various Agents |
3.1% |
Compartment Syndrome |
2.4% |
Neonatal Respiratory Depression |
2.4% |
Pulmonary Hypertension |
2.4% |
Cardiac Arrest |
1.6% |
Delayed Recovery From Anaesthesia |
1.6% |
Foetal Heart Rate Abnormal |
1.6% |
Foetal Heart Rate Deceleration |
1.6% |
Hyperaesthesia |
1.6% |
Loss Of Consciousness |
1.6% |
Muscle Contractions Involuntary |
1.6% |
Pulmonary Oedema |
1.6% |
Acute Coronary Syndrome |
0.8% |
Anaesthetic Complication Neurological |
0.8% |
Atrioventricular Block Second Degree |
0.8% |
Bradycardia |
0.8% |
|
Secondary |
Maintenance Of Anaesthesia |
15.8% |
Anaesthesia |
14.0% |
Induction Of Anaesthesia |
12.9% |
General Anaesthesia |
12.9% |
Prophylaxis |
8.9% |
Product Used For Unknown Indication |
8.8% |
Drug Use For Unknown Indication |
5.3% |
Laryngospasm |
4.2% |
Arrhythmia |
4.1% |
Sedation |
3.4% |
Analgesic Therapy |
1.9% |
Premedication |
1.6% |
Pain |
1.1% |
Induction And Maintenance Of Anaesthesia |
0.9% |
Analgesia |
0.8% |
Maternal Exposure Timing Unspecified |
0.8% |
Postoperative Analgesia |
0.8% |
Preoperative Care |
0.7% |
Analgesic Effect |
0.6% |
Depression |
0.6% |
|
Pneumonia |
15.2% |
Unwanted Awareness During Anaesthesia |
13.0% |
Hypoxia |
10.4% |
Delayed Recovery From Anaesthesia |
8.7% |
Respiratory Depression |
4.8% |
Laryngospasm |
3.9% |
Stress Cardiomyopathy |
3.9% |
Unresponsive To Stimuli |
3.9% |
Haemorrhage |
3.5% |
Ventricular Tachycardia |
3.5% |
Vomiting |
3.5% |
Anaphylactic Shock |
3.0% |
Drug Interaction |
3.0% |
Muscle Rigidity |
3.0% |
Respiratory Failure |
3.0% |
Vocal Cord Disorder |
3.0% |
White Blood Cell Count Increased |
3.0% |
Circulatory Collapse |
2.6% |
Hypotension |
2.6% |
Respiratory Arrest |
2.6% |
|
Concomitant |
Induction Of Anaesthesia |
19.8% |
Maintenance Of Anaesthesia |
13.9% |
Anaesthesia |
13.4% |
Product Used For Unknown Indication |
12.2% |
Drug Use For Unknown Indication |
9.7% |
General Anaesthesia |
7.4% |
Prophylaxis |
3.1% |
Sedation |
2.8% |
Analgesic Therapy |
2.2% |
Postoperative Analgesia |
1.9% |
Procedural Pain |
1.8% |
Induction And Maintenance Of Anaesthesia |
1.6% |
Endotracheal Intubation |
1.6% |
Hypertension |
1.3% |
Premedication |
1.3% |
Prophylaxis Of Nausea And Vomiting |
1.3% |
Antibiotic Prophylaxis |
1.2% |
Pathological Fracture |
1.2% |
Cerebral Disorder |
1.1% |
Infection |
1.1% |
|
Ventricular Tachycardia |
12.1% |
Serotonin Syndrome |
8.7% |
Hypersensitivity |
6.7% |
Anaphylactic Reaction |
6.0% |
Vomiting |
6.0% |
Cardiac Arrest |
5.4% |
Renal Failure Acute |
5.4% |
Respiratory Depression |
4.7% |
Tremor |
4.7% |
Anaphylactic Shock |
4.0% |
Nodal Rhythm |
4.0% |
Pneumonia |
4.0% |
Respiratory Arrest |
4.0% |
Ventricular Fibrillation |
4.0% |
Hyperthermia Malignant |
3.4% |
Hypotension |
3.4% |
Hypotonia |
3.4% |
Multi-organ Failure |
3.4% |
Muscle Spasms |
3.4% |
Status Epilepticus |
3.4% |
|
Interacting |
Anaesthesia |
13.3% |
Maintenance Of Anaesthesia |
13.3% |
Induction Of Anaesthesia |
12.4% |
General Anaesthesia |
11.4% |
Product Used For Unknown Indication |
8.6% |
Depression |
5.7% |
Anxiety |
4.8% |
Drug Use For Unknown Indication |
3.8% |
Hypertension |
3.8% |
Induction And Maintenance Of Anaesthesia |
3.8% |
Premedication |
3.8% |
Blood Pressure Fluctuation |
2.9% |
Prophylaxis Of Nausea And Vomiting |
2.9% |
Thyroglossal Cyst Excision |
2.9% |
Schizophrenia |
1.9% |
Blood Cholesterol Increased |
1.0% |
Endocarditis Prophylaxis |
1.0% |
Hypothyroidism |
1.0% |
Hypotonia |
1.0% |
Sedation |
1.0% |
|
Serotonin Syndrome |
31.3% |
Drug Interaction |
12.5% |
Opisthotonus |
12.5% |
Cardiac Arrest |
6.3% |
Coagulopathy |
6.3% |
Hypersensitivity |
6.3% |
Rash Erythematous |
6.3% |
Respiratory Depression |
6.3% |
Urticaria |
6.3% |
Ventricular Tachycardia |
6.3% |
|